Inventor
POWELL JR DANIEL J
US24 patents
⚠️ This page may combine multiple inventors who share the name “POWELL JR DANIEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
21 patentsUS9272002B2Mar 1, 2016
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
UNIV PENNSYLVANIA75 citations97
US9446105B2Sep 20, 2016
Chimeric antigen receptor specific for folate receptor β
UNIV PENNSYLVANIA34 citations94
US10273300B2Apr 30, 2019
Methods of making chimeric antigen receptor-expressing cells
UNIV PENNSYLVANIA26 citations92
US10117896B2Nov 6, 2018
Use of a trans-signaling approach in chimeric antigen receptors
UNIV PENNSYLVANIA14 citations92
US9708384B2Jul 18, 2017
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
UNIV PENNSYLVANIA28 citations92
US9598489B2Mar 21, 2017
Human alpha-folate receptor chimeric antigen receptor
UNIV PENNSYLVANIA20 citations92
US10844117B2Nov 24, 2020
Human alpha-folate receptor chimeric antigen receptor
UNIV PENNSYLVANIA6 citations84
US10829735B2Nov 10, 2020
Methods for improving the efficacy and expansion of immune cells
UNIV PENNSYLVANIA14 citations82
US10266580B2Apr 23, 2019
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
UNIV PENNSYLVANIA5 citations82
US11484552B2Nov 1, 2022
Use of trans-signaling approach in chimeric antigen receptors
UNIV PENNSYLVANIA2 citations73
US10233425B2Mar 19, 2019
CD137 enrichment for efficient tumor infiltrating lymphocyte selection
UNIV PENNSYLVANIA4 citations73
US12448431B2Oct 21, 2025
Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein
UNIV PENNSYLVANIA0 citations62
US12325756B2Jun 10, 2025
Use of trans-signaling approach in chimeric antigen receptors
UNIV PENNSYLVANIA0 citations62
US11345735B2May 31, 2022
Fully-human t-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein
UNIV PENNSYLVANIA0 citations62
US10900019B2Jan 26, 2021
CD137 enrichment for efficient tumor infiltrating lymphocyte selection
UNIV PENNSYLVANIA1 citations62
US11912753B2Feb 27, 2024
Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
UNIV PENNSYLVANIA0 citations61
US12122829B2Oct 22, 2024
Human alpha-folate receptor chimeric antigen receptor
UNIV PENNSYLVANIA0 citations60
US12410232B2Sep 9, 2025
Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
UNIV PENNSYLVANIA0 citations53
US11116795B2Sep 14, 2021
Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
UNIV PENNSYLVANIA0 citations53
US10414812B2Sep 17, 2019
Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein
UNIV PENNSYLVANIA0 citations52
US10538568B2Jan 21, 2020
Methods and compositions of a follicle stimulating hormone receptor immunoreceptor
UNIV PENNSYLVANIA0 citations44
NOVARTIS AG
3 patentsUS11161907B2Nov 2, 2021
Car-expressing cells against multiple tumor antigens and uses thereof
NOVARTIS AG19 citations86
US12240884B2Mar 4, 2025
Methods for improving the efficacy and expansion of immune cells
NOVARTIS AG2 citations72
US11896614B2Feb 13, 2024
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
NOVARTIS AG0 citations48